Association of coronary atherosclerosis with insulin resistance in patients with impaired glucose tolerance

Acta Cardiologica

Volumn 60, Issue 3, 2005, Pages 325-331

  Stochmal, Ewa ^a   Szurkowska, Magdalena ^a   Czarnecka, Danuta ^a   Stochmal, Anna ^a   Klecha, Artur ^a   Kawecka Jaszcz, Kalina ^a   Szybiński, Zbigniew ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atherosclerosis; Coronary arteries; Impaired glucose tolerance; Insulin resistance; Myocardial infarction; Risk factors

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULINEMIA; MALE; ORAL GLUCOSE TOLERANCE TEST; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; ROC CURVE;

EID: 20444478351     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.3.2005012     Document Type: Article

References (40)

1. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
2. Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002; 45: 1172-81.
3. Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, Collins D. Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT). Diab Care 2003; 26: 1513-7.
4. Festa A, D'Agostino R Jr, Rich SS, Jenny NS, Tracy RP, Haffner SM Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Circulation 2003; 107: 2422-7.
5. Szybinski Z, Szurkowska M. Insulinemia - a marker of early diagnosis and control of efficacy of treatment of type 2 diabetes. Pol Arch Int Med 2001; CVI 3: 793-800.
6. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres J-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69-75.
7. Stochmal A, Goldsztajn P, Kawecka-Jaszcz K, Kwaśniak M, Zdzienicka A, Hartwich J, Lubaszewski W, Dembińska-Kieć A. Relation between insulinaemia and lipoprotein composition in men with primary arterial hypertension with and without hypertriglyceridaemia. J Hum Hypertens 1995; 9: 113-7.
8. Nash DT. Insulin resistance, ADMA levels, and cardiovascular disease. JAMA 2002; 287: 1451-2.
9. Tanaka A, Ogita K, Sekine M, Numano F, Numano F, Reaven GM. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metabol 2000; 85: 3557-60.
10. Emdin M, Gastaldelli A, Muscelli E, Macerata A, Natali A, Camastra S. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 2001; 103: 513-9.
11. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-8.
12. Hedblad B, Nilsson P, Engstrom G, Berglund G, Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002; 19: 470-5.
13. Peter P, Nuttall SL, Kendall MJ. Insulin resistance - the new goal! J Clin Pharm Therap 2003; 28: 167-74.
14. Pyorala M, Miettinen H, Laakso M, Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study. Circulation 1998; 98: 398-404.
15. Solymoss B Ch, Marcil M, Chaour M, Gilfix BM, Poitras AM, Campeau L. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol 1995; 76: 1152-6.
16. Isomaa BO, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen M, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
17. Tsuruta M, Hashimoto R, Adachi H, Imaizumi T, Nomura G. Hyperinsulinaemia as a predictor of hypertension: an 11-year follow-up study in Japan. J Hypertens 1996; 14: 483-8.
18. Goodpaster BH, Theaete FL, Simoneau JA, Kelly DE, Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-85.
19. Zavaroni I, Mazza S, Fantuzzi M, Dall'Anglio E, Bonora E, Delsignore R, Passeri M, Reaven GM. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 1993; 243: 25-30.
20. Thogersen AM, Jansson JH, Boman K, Nilson TK, Weinehall L, Huhtasaari F, Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241-47.
21. Lindahl B, Asplund K, Eliasson M, Evrin P-E. Insulin resistance syndrome and fibrinolytic activity: the northern Sweden MONICA study. Int J Epidemiol 1996; 25: 291-9.
22. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003; 41: 1044-7.
23. Dhawan J, Bray CL. Relationship between angiographically assessed coronary artery disease, plasma insulin levels and lipids in Asians and Caucasians. Atherosclerosis 1994; 105: 35-41.
24. Fujiwara R, Kutsumi Y, Hayashi T, Nishio H, Koshino Y, Shimada Y, Nakai T, Miyabo S. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance. Am J Cardiol 1995; 75: 122-6.
25. Seibaek M, Sloth C, Vallebo L, Hansen T, Urhammer SA, Burchardt H, Torp-Pedersen Ch, Pedersen O, Hildebrandt P. Glucose tolerance status and severity of coronary artery disease in men referred to coronary arteriography. Am Heart J 1997; 133: 622-9.
26. Burchfield CM, Sharp DS, Curb JD, Rodriguez BL, Abbott RD, Arakaki R, Yano K. Hyperinsulinemia and cardiovascular disease in elderly men. Arterioscler Thromb Vasc Biol 1998; 18: 450-7.
27. Yki-Jarvinen H. Insulin resistance and endothelial dysfunction. Best Pract Res Clin Endocrinol Metab 2003; 17: 411-30.
28. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998; 83: 2773-6.
29. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809-17.
30. Negri M, Sheiban I, Arigliano PL, Tonni S, Montresor G, Carlini S, Manzato F. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1. Am J Cardiol 1993; 72: 397-401.
31. Kruszelnicka-Kwiatkowska O, Surdacki A, Goldsztajn P, Matysek J, Piwowarska W, Golay A. Relationship between hyperinsulinemia and angiographically defined coronary atherosclerosis in non-diabetic men. Diabetes Metab 2002; 28: 305-9.
32. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinaemia, as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356-61.
33. Yamamoto A, Yamamura T, Kawaguchi A, Kameda K, Matsuzawa Y. Triglyceride and glucose intolerance as a risk factor for coronary heart disease. Cardiology 1991; 78: 185-93.
34. Ariza CR, Frati AC, Gomez G, Almazan A. Hyperinsulinemia in patients with coronary heart disease in absence of overt risk factors. Arch Med Research 1997; 28: 115-9.
35. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993; 91: 29-37.
36. Shimabukuro M, Shinzato T, Higa S, Chibana T, Yoshida H, Nagamine F, Murakami K, Takasu N. Enhanced insulin response relates to acetylocholine- induced vasoconstriction in vasospastic angina. J Am Coll Cardiol 1995; 25: 356-61.
37. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Kara Y, Tsushima M, Harano Y. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for Vasospastic Angina. Circulation 1995; 92: 1749-57.
38. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996; 98: 2094-9.
39. Hsueh WA, Lyon CI, Quinones MJ. Insulin resistance and the endothelium. Am J Med 2004; 117: 109-17.
40. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrin Metab 1995; 80: 829-35.